KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Moderna (MRNA) Inventory Average: 2021-2025

Historic Inventory Average for Moderna (MRNA) over the last 5 years, with Sep 2025 value amounting to $286.0 million.

  • Moderna's Inventory Average fell 29.47% to $286.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $286.0 million, marking a year-over-year decrease of 29.47%. This contributed to the annual value of $159.5 million for FY2024, which is 72.28% down from last year.
  • As of Q3 2025, Moderna's Inventory Average stood at $286.0 million, which was up 55.43% from $184.0 million recorded in Q2 2025.
  • Over the past 5 years, Moderna's Inventory Average peaked at $2.0 billion during Q3 2022, and registered a low of $122.5 million during Q1 2025.
  • Moreover, its 3-year median value for Inventory Average was $344.5 million (2023), whereas its average is $397.0 million.
  • Its Inventory Average has fluctuated over the past 5 years, first surged by 525.32% in 2022, then tumbled by 77.23% in 2023.
  • Moderna's Inventory Average (Quarterly) stood at $1.2 billion in 2021, then climbed by 25.77% to $1.5 billion in 2022, then crashed by 77.23% to $344.5 million in 2023, then fell by 23.22% to $264.5 million in 2024, then declined by 29.47% to $286.0 million in 2025.
  • Its Inventory Average was $286.0 million in Q3 2025, compared to $184.0 million in Q2 2025 and $122.5 million in Q1 2025.